Silence Therapeutics (SLN) Free Cash Flow: 2020-2025
Historic Free Cash Flow for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -$10.9 million.
- Silence Therapeutics' Free Cash Flow rose 57.53% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.6 million, marking a year-over-year decrease of 15.70%. This contributed to the annual value of -$67.9 million for FY2024, which is 37.02% down from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Free Cash Flow is -$10.9 million, which was up 50.08% from -$21.8 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Free Cash Flow registered a high of $36.4 million during Q2 2021, and its lowest value of -$27.5 million during Q4 2024.
- In the last 3 years, Silence Therapeutics' Free Cash Flow had a median value of -$12.3 million in 2025 and averaged -$15.4 million.
- Per our database at Business Quant, Silence Therapeutics' Free Cash Flow spiked by 73.28% in 2021 and then tumbled by 429.09% in 2022.
- Silence Therapeutics' Free Cash Flow (Quarterly) stood at -$3.0 million in 2021, then plummeted by 429.09% to -$15.7 million in 2022, then slumped by 42.66% to -$22.4 million in 2023, then decreased by 22.76% to -$27.5 million in 2024, then skyrocketed by 57.53% to -$10.9 million in 2025.
- Its Free Cash Flow was -$10.9 million in Q3 2025, compared to -$21.8 million in Q2 2025 and -$12.3 million in Q1 2025.